Lauren A. Byers

Forest Institute — United States

Medicine · Health Sciences

74h-index24.3kcitations866works5.22yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Lung Cancer Research Studies(304), Lung Cancer Treatments and Mutations(202), RNA modifications and cancer(152), Neuroendocrine Tumor Research Advances(102), Peptidase Inhibition and Analysis(94)

Publications866 total

Small Cell Lung Cancer Classification: Unraveling Heterogeneity to Enable Personalized Treatments
Cancer Research·2025Open Access
Development of PET/CT-clinical nomograms for predicting lymph node metastasis in primary lung cancer
European Radiology·2025Open Access
Multi-omic profiling provides insights into the heterogeneity, microenvironmental features, and biomarker landscape of small-cell lung cancer
Molecular Cancer·2025· 2 citedOpen Access
MET Overexpression Is Associated with Superior Immunotherapy Benefit in Advanced Non-Small Cell Lung Cancer
Cancers·2025Open Access
Supplementary Figure 2 from Targeting BCL2 Overcomes Resistance and Augments Response to Aurora Kinase B Inhibition by AZD2811 in Small Cell Lung Cancer
2025Open Access
Supplementary Data 1 from Targeting BCL2 Overcomes Resistance and Augments Response to Aurora Kinase B Inhibition by AZD2811 in Small Cell Lung Cancer
2025Open Access
Supplementary Figure 3 from Targeting BCL2 Overcomes Resistance and Augments Response to Aurora Kinase B Inhibition by AZD2811 in Small Cell Lung Cancer
2025Open Access
Supplementary Figure 1 from Targeting BCL2 Overcomes Resistance and Augments Response to Aurora Kinase B Inhibition by AZD2811 in Small Cell Lung Cancer
2025Open Access
Supplementary Figure 4 from Targeting BCL2 Overcomes Resistance and Augments Response to Aurora Kinase B Inhibition by AZD2811 in Small Cell Lung Cancer
2025Open Access
Supplementary Table 1 from Early ctDNA Dynamics Inform First-Line Therapy in Patients with Extensive-Stage Small Cell Lung Cancer
2025Open Access
Data from Early ctDNA Dynamics Inform First-Line Therapy in Patients with Extensive-Stage Small Cell Lung Cancer
2025Open Access
Supplementary Figure 3 from Early ctDNA Dynamics Inform First-Line Therapy in Patients with Extensive-Stage Small Cell Lung Cancer
2025Open Access
Supplementary Figure 6 from Early ctDNA Dynamics Inform First-Line Therapy in Patients with Extensive-Stage Small Cell Lung Cancer
2025Open Access
Supplementary Figure 1 from Early ctDNA Dynamics Inform First-Line Therapy in Patients with Extensive-Stage Small Cell Lung Cancer
2025Open Access
Supplementary Figure 4 from Early ctDNA Dynamics Inform First-Line Therapy in Patients with Extensive-Stage Small Cell Lung Cancer
2025Open Access
Supplementary Figure 7 from Early ctDNA Dynamics Inform First-Line Therapy in Patients with Extensive-Stage Small Cell Lung Cancer
2025Open Access
Supplementary Figure 2 from Early ctDNA Dynamics Inform First-Line Therapy in Patients with Extensive-Stage Small Cell Lung Cancer
2025Open Access
Supplementary Figure 5 from Early ctDNA Dynamics Inform First-Line Therapy in Patients with Extensive-Stage Small Cell Lung Cancer
2025Open Access
YAP1 defines an emergent, plastic population of relapsed small cell lung cancer
2025Open Access
CoCo-ST detects global and local biological structures in spatial transcriptomics datasets
Nature Cell Biology·2025Open Access
page 1 of 44Next →

Frequent Co-authors

John V. Heymach(35), Ignacio I. Wistuba(27), Don L. Gibbons(21), Lixia Diao(18), Jing Wang(17), John D. Minna(15), Carl M. Gay(12), Bonnie S. Glisson(12), Junya Fujimoto(10), Ferdinandos Skoulidis(9), Vassiliki A. Papadimitrakopoulou(9), Edwin R. Parra(9), Charles M. Rudin(8), J. Jack Lee(8), Carmen Behrens(7), Stephen G. Swisher(7), Tina Cascone(7), You-Hong Fan(6), Kevin R. Coombes(6), David H. Peng(6)